CBS: Questions remain about COVID-19 booster shots
UC's Dr. Trisha Wise-Draper recommends third dose of mRNA vaccines to boost antibody production
While federal officials continue to analyze the need for the general public to receive a third dose of the currently available mRNA COVID-19 vaccines, certain immunocompromised groups are already eligible for a booster shot.
Dr. Trisha Wise-Draper, medical director of the UC Cancer Center's Clinical Trial Office and UC associate professor of medicine in the Division of Hematology/Oncology, said research has shown cancer patients in particular should receive a third dose as soon as possible.
"Certain cancer patients, especially those with blood disorders, are more at risk of not developing antibodies to the vaccine and remain vulnerable to the infection,” Wise-Draper told Local 12 News, in a story that was picked up nationally by news affiliates. "[Many patients] are at exceedingly high risk of serious disease and mortality from COVID-19."
Watch the full Local 12 report.
Featured photo at top: Shutterstock.com
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.
What is squalane, and how does it work to moisturize skin?
October 27, 2025
The University of Cincinnati's Kelly Dobos was featured in a Women's Health article discussing squalane, an ingredient being increasingly used in moisturizing skincare products.